Tag: 1

TORONTO, ONTARIO, June 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) (“COSCIENS” or the “Company”), a life sciences company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announced the voting results on the items of business considered at the virtual annual general and special meeting of shareholders of the Company (the “AGSM”) held today.

MONTRÉAL, 30 juin 2025 (GLOBE NEWSWIRE) -- Bombardier annonce fièrement aujourd’hui une commande ferme de 50 de ses avions Challenger et Global à la fine pointe de la performance, combinée à une entente de services inédite. Ensemble, la commande ferme d’avions et l’entente de services sont évaluées à 1,7 milliard $ US, les livraisons devant débuter en 2027¹. Le nouveau client de Bombardier conservera également 70 options d’achat de nouveaux avions. Si toutes les options d’achat sont exercées, la valeur combinée des avions et de l’entente de services s’élèverait à plus de 4 milliards $ US². Le client a choisi les services de maintenance de premier ordre de Bombardier pour créer un partenariat novateur qui assurera un niveau de soutien et de commodité inégalé pour les clients. Le client a décidé de garder l’anonymat avant de dévoiler son offre sur le marché.

MONTREAL, June 30, 2025 (GLOBE NEWSWIRE) -- Bombardier proudly announces a significant firm order for 50 of its performance-leading Challenger and Global aircraft, combined with a first-of-a-kind service agreement. Together, the firm aircraft and service agreements are valued at US$1.7 billion with deliveries set to begin in 2027¹. The first-time Bombardier customer will also hold 70 new aircraft purchase options. If all purchase options are exercised, the combined aircraft and service agreements’ value would reach more than US$4 billion². The customer has selected Bombardier’s top-ranked maintenance offerings to create an innovative partnership that will deliver an unmatched level of care and convenience for customers. The customer has elected to remain anonymous prior to unveiling their offering in the marketplace.

Reykjavík, 30 June 2025 – Kaldalón hf. (“Kaldalón” or the “Company”) announces the implementation of a share buyback program based on the authorization granted by the Company’s shareholders’ meeting held on 2 July 2024.

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and June 23, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 25, 2025.

Strengthens Financial Position with Expanded Credit Facility and Flexibility for Future Strategic Equity Sales